Display Settings:

Format

Send to:

Choose Destination
    Hum Mol Genet. 2009 Mar 15;18(6):1131-9. Epub 2009 Jan 6.

    Association of ESR1 gene tagging SNPs with breast cancer risk.

    Source

    Department of Oncology, University of Cambridge, Cambridge, UK. alisond@srl.cam.ac.uk

    Abstract

    We have conducted a three-stage, comprehensive single nucleotide polymorphism (SNP)-tagging association study of ESR1 gene variants (SNPs) in more than 55,000 breast cancer cases and controls from studies within the Breast Cancer Association Consortium (BCAC). No large risks or highly significant associations were revealed. SNP rs3020314, tagging a region of ESR1 intron 4, is associated with an increase in breast cancer susceptibility with a dominant mode of action in European populations. Carriers of the c-allele have an odds ratio (OR) of 1.05 [95% Confidence Intervals (CI) 1.02-1.09] relative to t-allele homozygotes, P = 0.004. There is significant heterogeneity between studies, P = 0.002. The increased risk appears largely confined to oestrogen receptor-positive tumour risk. The region tagged by SNP rs3020314 contains sequence that is more highly conserved across mammalian species than the rest of intron 4, and it may subtly alter the ratio of two mRNA splice forms.

    PMID:
    19126777
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2722230
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 1.
    Figure 3.
    Figure 2.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk